drugset / Trial / NCT01876108
The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The role of Helicobacter pylori(HP)in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) is controversial.
Timeline
- Start
- 2012-07
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1 g | — |
| Subject | Azithromycin | Small molecule | 500 mg | — |
| Subject | Bismuth subcitrate | Unknown | 240 mg | — |
| Subject | Omeprazole | Other / unclassified | 20 mg | — |